Back to Newsroom

Alder BioPharmaceuticals to Present at the Credit Suisse 24th Annual Healthcare Conference

BOTHELL, Wash., November 3, 2015 – Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease, Congenital Adrenal Hyperplasia and autoimmune and inflammatory diseases, today announced that Randall C. Schatzman, Ph.D., President and Chief Executive Officer, will present at the Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10, 2015 at 10:30 a.m. MT in Scottsdale, AZ.

Click here to read more